LDHC is expressed in serum and serum exosomes of tumor patients, with serum LDHC positivity rates of 91.66%, 68%, and 65% in BC (36), HCC (37), and LUAD (63), respectively. Here, LDHC is linked to hepatocellular carcinoma.